Patent · US Active

Method of lyophilizing liposomes

US10166184B2 · kind B2 · utility

4Cited by

9References

17Claims

0Family size

Assignee

Celator Pharmaceuticals, Inc. · US

Inventors

Donna Cabral-Lilly · Princeton, US
Lawrence Mayer · Vancouver, CA
Paul Tardi · Surrey, CA
David WATKINS · East Greenwich, US
Yi Zeng · Chengdu, CN

Key dates

Filing date	Feb 7, 2018
Grant date	Jan 1, 2019
Priority date	—
Expiry date	Feb 7, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Lyophilized liposomal formulations with two or more encapsulated drugs are disclosed. These formulations display superior drug retention profiles and also maintain size distribution following lyophilization and reconstitution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.